rs150393340
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_017890.5(VPS13B):c.11233G>A(p.Glu3745Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000221 in 1,595,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017890.5 missense
Scores
Clinical Significance
Conservation
Publications
- Cohen syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VPS13B | ENST00000358544.7 | c.11233G>A | p.Glu3745Lys | missense_variant | Exon 58 of 62 | 1 | NM_017890.5 | ENSP00000351346.2 | ||
| VPS13B | ENST00000357162.7 | c.11158G>A | p.Glu3720Lys | missense_variant | Exon 58 of 62 | 1 | NM_152564.5 | ENSP00000349685.2 |
Frequencies
GnomAD3 genomes AF: 0.00109 AC: 166AN: 152142Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000239 AC: 51AN: 213028 AF XY: 0.000165 show subpopulations
GnomAD4 exome AF: 0.000129 AC: 186AN: 1443582Hom.: 0 Cov.: 32 AF XY: 0.000120 AC XY: 86AN XY: 716196 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00109 AC: 166AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.00113 AC XY: 84AN XY: 74442 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cohen syndrome Benign:3
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
- -
not provided Uncertain:1Benign:1
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The p.E3745K variant (also known as c.11233G>A), located in coding exon 57 of the VPS13B gene, results from a G to A substitution at nucleotide position 11233. The glutamic acid at codon 3745 is replaced by lysine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -
VPS13B-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at